<DOC>
	<DOCNO>NCT02940379</DOCNO>
	<brief_summary>Primary Objective : To assess effect repeat once-daily oral dos sotagliflozin CYP2D6 CYP3A activity use CYP probe cocktail metoprolol midazolam . Secondary Objective : To assess clinical laboratory safety sotagliflozin coadministered cocktail probe compare cocktail probe alone .</brief_summary>
	<brief_title>A Drug Drug Interaction Study Sotagliflozin With Midazolam Metoprolol</brief_title>
	<detailed_description>The total study duration per subject 58 day .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Inclusion criterion : Male female healthy subject , 18 55 year age , inclusive . Body weight 50.0 100.0 kg , inclusive , male , 40.0 90.0 kg , inclusive , female , body mass index 18.0 30.0 kg/m^2 , inclusive . Normal vital sign , electrocardiogram ( ECG ) , laboratory parameter Female subject must use double contraception method study , except undergone sterilization least 3 month earlier postmenopausal . The accepted double contraception method include use one follow contraceptive option : ( 1 ) condom ; ( 2 ) diaphragm cervical/vault cap ; ( 3 ) spermicide addition use one following : ) Intrauterine device ( IUD ) ; b ) Vasectomized partner ; c ) Sexual abstinence . Hormonal contraception NOT acceptable study . Exclusion criterion : Any history presence clinically relevant cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , hematological , neurological , osteomuscular , articular , psychiatric , systemic , ocular , infectious disease , sign acute illness . Frequent headache and/or migraine , recurrent nausea and/or vomit . Blood donation , volume , within 2 month inclusion . Symptomatic postural hypotension . Presence history drug hypersensitivity , allergic disease asthma diagnose treated physician . History presence drug alcohol abuse . If female , pregnancy breastfeeding . Any medication ( include St John 's Wort ) within 14 day inclusion within 5 time elimination halflife pharmacodynamic halflife medication ; vaccination within last 28 day biologics ( antibody derivative ) give within 4 month inclusion . Any oral contraceptive screen period least 15 day prior first dose Period 1 ; injectable contraceptive hormonal intrauterine device within 12 month prior first dose Period 1 ; topical control delivery contraceptive ( patch ) 3 month prior first dose Period 1 . Any contraindication metoprolol , accord applicable labeling . Any contraindication midazolam , accord applicable labeling . Any consumption citrus ( grapefruit , orange , etc . ) juice within 5 day inclusion . Any history presence deep leg vein thrombosis embolism recurrent frequent appearance deep leg vein thrombosis first degree relative ( parent , sibling child ) . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>